About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sodium Tungstate in Obesity

NCT00555074·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospital Clinic of Barcelona

With

Fundacio Clinic Barcelona

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

BMI: 30-39.9 Kg/m2
In case of male gender, 18 to 65 years old
In case of female gender, diagnosis of menopause
Body weight changes \< 3 kg in the last 3 months
In case of arterial hypertension or dyslipemia, no changes in dose in the last 2 months

You may not be if

In case of female gender, absence of menopause
Evidence of secondary causes of obesity
Diabetes, type II
Concomitant treatment with drugs affecting body weight
Previous surgical intervention of obesity

The record

StatusCompleted

PhasePhase 2

Taking part44

StartedNov 2007

UpdatedMar 31, 2010

Conditions

Where1

Hospiral Clinic de Barcelona
Barcelona, Barcelona, Spain

Clareo Health | Sodium Tungstate in Obesity